More recently, the 3CL pro peptidomimetic inhibitor PF-07321332 has shown promising results in phase I clinical trials, thus paving the way toward the discovery of an effective antiviral (Owen et al., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback